Evidence map›Paper›PMID 33238435›Full record

ReviewMolecules (Basel, Switzerland)2020

An Overview of Nrf2 Signaling Pathway and Its Role in Inflammation.

Sarmistha Saha, Brigitta Buttari, Emiliano Panieri, Elisabetta Profumo, Luciano Saso

Open access · goldAbstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 737 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
737citing papers in PubMed, 2 pooled it
47.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

737 citing papers in PubMed, 2 syntheses or guidelines pooled it, 1,266 citations in OpenAlex.

  1. Pooled it
  2. The Role of c-Abl in Alzheimer's Disease: Guilty or not Guilty?Cellular and molecular neurobiology · 2025
    Pooled it
  3. Trial
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Review
  15. Genetic and pharmacologic modulations elucidate NRF2 protective role in acute pancreatitis.American journal of physiology. Gastrointestinal and liver physiology · 2026
    Article
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review

677 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Sarmistha SahaDepartment of Cardiovascular, Endocrine-Metabolic Diseases and Aging, Italian National Institute of Health, 00161 Rome, Italy.
Brigitta ButtariDepartment of Cardiovascular, Endocrine-Metabolic Diseases and Aging, Italian National Institute of Health, 00161 Rome, Italy.ORCID 0000-0002-0575-4106
Emiliano PanieriDepartment of Physiology and Pharmacology "Vittorio Erspamer", Sapienza University of Rome, 00161 Rome, Italy.ORCID 0000-0001-7989-7145
Elisabetta ProfumoDepartment of Cardiovascular, Endocrine-Metabolic Diseases and Aging, Italian National Institute of Health, 00161 Rome, Italy.ORCID 0000-0002-7261-8884
Luciano SasoDepartment of Physiology and Pharmacology "Vittorio Erspamer", Sapienza University of Rome, 00161 Rome, Italy.ORCID 0000-0003-4530-8706
Sapienza University of Rome · IT

Funding

European Molecular Biology Organization 8142
6 · The paper itself

Abstract

Inflammation is a key driver in many pathological conditions such as allergy, cancer, Alzheimer's disease, and many others, and the current state of available drugs prompted researchers to explore new therapeutic targets. In this context, accumulating evidence indicates that the transcription factor Nrf2 plays a pivotal role controlling the expression of antioxidant genes that ultimately exert anti-inflammatory functions. Nrf2 and its principal negative regulator, the E3 ligase adaptor Kelch-like ECH- associated protein 1 (Keap1), play a central role in the maintenance of intracellular redox homeostasis and regulation of inflammation. Interestingly, Nrf2 is proved to contribute to the regulation of the heme oxygenase-1 (HO-1) axis, which is a potent anti-inflammatory target. Recent studies showed a connection between the Nrf2/antioxidant response element (ARE) system and the expression of inflammatory mediators, NF-κB pathway and macrophage metabolism. This suggests a new strategy for designing chemical agents as modulators of Nrf2 dependent pathways to target the immune response. Therefore, the present review will examine the relationship between Nrf2 signaling and the inflammation as well as possible approaches for the therapeutic modulation of this pathway.

Indexed as

Disease SusceptibilitySignal TransductionAnimalsBiomarkersGene Expression RegulationHumansInflammationKelch-Like ECH-Associated Protein 1NF-E2-Related Factor 2NF-kappa BOxidation-ReductionOxidative StressProtein BindingStructure-Activity RelationshipBiomarkersKelch-Like ECH-Associated Protein 1NFE2L2 protein, humanNF-E2-Related Factor 2NF-kappa BinflammationKeap1Nrf2oxidative stresspolyphenols

Identifiers

PMID33238435
PMCPMC7700122
OpenAlexW3110258185

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.